Changes of miR-132-3p in rat peritoneum. حسب Yangyang Yin (14323701)

الموضوعات:

Subgroup changes in hs-CRP. حسب Aernoud T. L. Fiolet (9322862)

To assess the effect of IL-1ß on expression of sclerostin, ATDC5 cells were cultured for 3 weeks in chondrogenic media and then 10 ng/ml IL-1β was added to the media for 24 hours.... حسب Kazuma Miyatake (5587748)

<b>Diroximel fumarate acts through Nrf2 to attenuate methylglyoxal-induced nociception in mice and decrease ISR activation in DRG neurons</b> حسب Muhammad Saad Yousuf (20745168)

Klf5 expression is down-regulated in the ruptured human and experimental AAA. حسب Dong Ma (584680)

Changes of anti-oxidative enzyme and oxidative stress after in a mouse model of kidney fibrosis. حسب Wencheng Jin (13136262)

الموضوعات:

Changes related to kidney staining in UUO mouse model. حسب Wencheng Jin (13136262)

الموضوعات:

Changes associated with kidney fibrosis and effects of MN705 treatment on TGF- حسب Wencheng Jin (13136262)

الموضوعات:

The screening process of MN705. حسب Wencheng Jin (13136262)

الموضوعات:

Changes associated with kidney fibrosis in TGF- حسب Wencheng Jin (13136262)

الموضوعات:

Effect of MN705 treatment on TGF- حسب Wencheng Jin (13136262)

الموضوعات:

Validation of MN705 treatment effects in human proximal tubular epithelial cells during TGF- حسب Wencheng Jin (13136262)

الموضوعات:

Flowchart of study selection. حسب Alejandro Piscoya (782326)

Description of characteristics of included studies. حسب Alejandro Piscoya (782326)

Effect of remdesivir on invasive ventilation at 14 days. حسب Alejandro Piscoya (782326)

Effect of remdesivir on all-cause mortality at 14 days. حسب Alejandro Piscoya (782326)

Summary of findings table for the comparison remdesivir 10 days vs. placebo for hospitalized, severe COVID-19. حسب Alejandro Piscoya (782326)

Summary of findings table for the comparison remdesivir 5 days vs. standard of care for hospitalized, moderate COVID-19. حسب Alejandro Piscoya (782326)

Summary of findings table for the comparison of remdesivir 5 days vs. remdesivir 10 days for hospitalized, severe COVID-19. حسب Alejandro Piscoya (782326)

Regadenoson increases survival of SARS-CoV-2-infected K18-mice. حسب Joseph Rabin (7399436)

الموضوعات: